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Abstract
Cadmium is a highly toxic environmental contaminant implicated in various diseases. Our previous data demonstrated that Pca1, 
a P1B-type ATPase, plays a critical role in cadmium resistance in yeast S. cerevisiae by extruding intracellular cadmium. This il-
lustrates the first cadmium-specific efflux pump in eukaryotes. In response to cadmium, yeast cells rapidly enhance expression 
of Pca1 by a post-transcriptional mechanism. To gain mechanistic insights into the cadmium-dependent control of Pca1 expres-
sion, we have characterized the pathway for Pca1 turnover and the mechanism of cadmium sensing that leads to up-regulation of 
Pca1. Pca1 is a short-lived protein (t½ < 5 min) and is subject to ubiquitination when cells are growing in media lacking cadmium. 
Distinct from many plasma membrane transporters targeted to the vacuole for degradation via endocytosis, cells defective in this 
pathway did not stabilize Pca1. Rather, Pca1 turnover was dependent on the proteasome. These data suggest that, in the absence 
of cadmium, Pca1 is targeted for degradation before reaching the plasma membrane. Mapping of the N terminus of Pca1 identi-
fied a metal-responding degradation signal encompassing amino acids 250–350. Fusion of this domain to a stable protein demon-
strated that it functions autonomously in a metal-responsive manner. Cadmium sensing by cysteine residues within this domain 
circumvents ubiquitination and degradation of Pca1. These data reveal a new mechanism for substrate-mediated control of P1B-
type ATPase expression. Cells have likely evolved this mode of regulation for a rapid and specific cellular response to cadmium. 
Abbreviations: SC, synthetic complete; GFP, green fluorescent protein; HA, hemagglutinin; PBS, phosphate-buffered saline; PGK, 
phosphoglycerate kinase; E3, ubiquitin-protein isopeptide ligase; WT, wild type; MBD, metal-binding domain.
Introduction
Although several heavy metals are essential micronutri-
ents, many of them are highly toxic with no physiological 
role. Genetic disorders in metal metabolism, such as hemo-
chromatosis and Wilson disease, provide striking evidence 
for the toxicity of nutritional metal ions (1–3). Toxic heavy 
metals in the environment such as cadmium, lead, and mer-
cury are linked to a number of human disorders, including 
cancer, organ damage, and reproductive defects (4–7). For 
instance, cadmium has a high affinity for sulfhydryl (-SH) 
groups in proteins and glutathione, a major cellular reducing 
buffer, which results in inactivation of proteins and oxidative 
stress (4, 9, 10). Cadmium markedly increases mutation rates 
by specifically inhibiting the DNA mismatch repair system 
(11). Estrogenic effects of cadmium also lead to infertility and 
cancer (12–14). Human exposure to cadmium through diet, 
smoking, pollution, and occupation is widespread (4, 5, 8). 
Organisms have evolved systems for excretion and de-
toxification of nonphysiological metals and homeostatic ac-
quisition of nutritional yet toxic metals. Metal transporters, 
cytosolic delivery molecules, and chelators have been iden-
tified in many organisms ranging from bacteria to humans 
(1, 3, 26–28). Given that cadmium is not a nutritional metal 
ion, organisms do not actively acquire cadmium. Rather, 
cadmium enters the body through nonspecific mechanisms 
and/or transporters involved in the acquisition of essential 
metal ions. DMT1 (DCT1, Nramp2) iron transporter, zinc 
transporters, and calcium channels are all involved in cad-
mium absorption (15–19). Metallothionein, a cysteine-rich 
low molecular weight metalchelating peptide, and GSH, a 
cysteine-containing tripeptide, sequester metal ions. In eu-
karyotes, this is considered the major mechanism for neu-
tralizing toxic metals, including cadmium (20–23). Ace1 is a 
transcription factor inducing expression of copper defense 
genes in S. cerevisiae (24). Ycf1, a vacuolar membrane ATP-
binding cassette transporter, sequesters glutathione-conju-
gated cadmium and other metals into the vacuole (25). Thus, 
Δace1 and Δycf1 strains are sensitive to copper and cadmium, 
respectively. Phytochelatin, a GSH polymer synthesized in 
plants and fission yeast, also chelates heavy metals (21). Sev-
eral heavy metal efflux pumps, including P1B-type ATPases, 
ATP-binding cassette transporters, and cation diffusion facil-
itators play roles for extruding toxic heavy metals (3, 26–28). 
These metal transporters play vital roles for uptake, com-
partmentalization, and extrusion of nutritional and nonphys-
iological heavy metals. In bacterial cells, P1B-type ATPases 
are vital for extrusion of metals, including cadmium, copper, 
and lead (26, 27). However, the cadmium efflux systems in 
eukaryotes remain uncharacterized. Transcriptional control 
appears to be a major regulatory mechanism for regulation 
of P1B-type ATPases in bacteria and plants (26–28). In mam-
mals copper controls subcellular trafficking of copper-trans-
porting P1B-type ATPases from the trans-Golgi to the plasma 
membrane and cytoplasmic vesicle-like compartments (3, 
29), which appears to be an important mechanism for excre-
tion of excess copper. 
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In a previous study, we demonstrated that Pca1, a pre-
dicted P1B-type metal-transporting ATPase, is critical for cad-
mium defense in yeast Saccharomyces cerevisiae (30). Pca1 is 
rapidly up-regulated in response to cadmium without any 
change in its transcript levels (30), which suggests a new mode 
of substrate-mediated regulation for this family of proteins. To 
elucidate the mechanisms underlying the expressional con-
trol of Pca1 in response to cadmium, we have characterized 
the pathways for turnover of Pca1 and identified a metal-sens-
ing cis-acting element that controls turnover of Pca1. Our data 
demonstrate that a degradation signal within the cysteine-rich 
N terminus rapidly targets Pca1 for ubiquitination and deg-
radation by the proteasome. This occurs before Pca1 reaches 
the plasma membrane where it extrudes cadmium. However, 
direct cadmium sensing by the degradation signal prevents 
turnover, which leads to enhanced expression of Pca1. Cells 
have likely evolved this mode of regulation for a rapid and 
specific response against cadmium. Together, we have identi-
fied a new metal-binding domain and revealed a unique mode 
of regulation for a P1B-type ATPase by its own substrate. 
Experimental Procedures
Yeast Strains, Media, and Growth Conditions—A BY4741 
haploid S. cerevisiae strain (MATa his3Δ1, leu2Δ0, met15Δ0, 
ura3Δ0) and null mutants, including ace1::KanMX6, ycf1:: 
KanMX6, pep4::KanMX6, vps4::KanMX6, and pdr5::KanMX6 
strains, were purchased from OpenBiosystems. Gene dele-
tion in each strain was confirmed by PCR using gene-specific 
primer sets. We received end4-1 (31), npi1 (32), and pre1-1 
pre2-1 (33) strains from Drs. Caroline Philpott (National In-
stitute of Health), Bruno André, (Université Libre de Brux-
elles), and Dieter Wolf (Universität Stuttgart), respectively. 
Yeast cells were cultured with synthetic complete (SC)2 me-
dium (2% dextrose, 0.2% amino acid mixture, and 0.67% 
yeast nitrogen base) lacking specific amino acids for plasmid 
selection. If no temperature is specified, the cells were cul-
tured at 30 °C. For phenotypical analysis on solid medium 
(1.5% agar), 5 µl of yeast cells (A600 = 1.0) were spotted on se-
lective medium supplemented with the indicated concentra-
tions of cadmium (CdCl2) or copper (CuCl2) and incubated at 
30 °C for 2 days before photography. Cycloheximide chases 
were performed by the addition of 100 µg/ml cycloheximide 
to logarithmically growing cultures prior to collection into 
equal volumes of ice-cold kill buffer (phosphate-buffered 
saline (PBS) containing 15 mM NaN3) at the indicated time 
points. For proteasome inhibition, a Δpdr5 strain that blocks 
proteasome inhibitor efflux (34), was cultured for 5 h in the 
presence of 40 µM MG132 (Calbiochem) in 0.1% dimethyl 
sulfoxide (Sigma). 
Plasmid Construction and Manipulation—If no expression 
vector is specified, single copy yeast vectors (p416-GPD) (35) 
were used for glyceradehyde-3-phosphate dehydrogenase 
gene promoter-driven constitutive expression of Pca1, N-ter-
minal truncated Pca1, CaCRP, Pca1-CaCRP fusion, N-termi-
nal 250–350 peptide, Fet3 iron oxidase, CL1 degradation sig-
nal peptide, and Gap1 general amino acid permease. For the 
green fluorescent protein (GFP) or hemagglutinin (HA) epit-
ope fusion, NotI-flanked GFP or three tandem HA epitopes 
were inserted into the NotI site, which was artificially gen-
erated after ATG translation start codon by PCR. Expres-
sion plasmids of CL1 artificial degradation signal fused with 
GFP were constructed as described (36, 45). Site-directed mu-
tagenesis was conducted by the primer overlap extension 
method (37). We sequenced all constructs to confirm correct 
sequence and in frame fusion. Common molecular biology 
techniques, including plasmid amplification using Escherichia 
coli, and purification, followed previously established meth-
ods (38). Plasmid transformation into yeast was performed 
using the lithium acetate method (39). 
Fluorescence Microscopy—Yeast cells were cultured in SC 
selective medium at 30 °C with agitation until mid-log phase. 
When indicated, metals (CdCl2 or CuCl2) were added to the 
culture medium prior to imaging. The cells were collected, 
resuspended in PBS, and imaged on a confocal microscope 
(Olympus FV500) as described (30). 
Immunoblotting—Total protein extracts were prepared by 
breaking cells with glass beads in PBS containing protease 
inhibitor mixture (Complete Mini) (Roche Applied Science) 
and 1% Triton X-100. Protein concentrations were measured 
using the BCA kit (Pierce) according to the manufacturer’s 
specifications. The lysates were denatured in SDS sample 
buffer containing dithiothreitol (25 mM) for 15 min at 37 °C, 
resolved by SDS-PAGE, and transferred to a nitrocellulose 
membrane. GFP fusion proteins were detected by rabbit anti-
GFP polyclonal antibodies (Santa Cruz Biotechnology Inc.) 
and secondary goat anti-rabbit IgG antibodies conjugated 
to horseradish peroxidase (Santa Cruz Biotechnology Inc.). 
HA-tagged proteins were probed with rabbit anti-HA poly-
clonal antibodies (Rockland) and secondary goat anti-rabbit 
IgG antibodies conjugated to horseradish peroxidase (Santa 
Cruz Biotechnology Inc.). Loading control, 3-phosphoglycer-
ate kinase (PGK), was detected with mouse monoclonal anti-
PGK antibodies (Molecular Probes) and secondary sheep 
anti-mouse IgG antibodies conjugated to horseradish peroxi-
dase (Amersham Biosciences). The signals were captured on 
film (Midwest Scientific) by chemiluminescence (SuperSig-
nal West Pico) (Pierce). 
Detection of Ubiquitination—The cells were broken by glass 
beads in PBS containing protease inhibitors (Complete Mini) 
(Roche Applied Science), 5 mM N-ethylmaleimide, 1 mM 
phenylmethylsulfonyl fluoride, and 1% Triton X-100. HA-
tagged proteins were immunoprecipitated with a ProFoundTM 
HA tag IP/Co-IP kit (Pierce) according to the manufacturer’s 
specifications. The proteins were eluted by incubation of im-
mobilized anti-HA agarose beads in 2x SDS sample buffer at 
37 °C for 15 min and reduced in the presence of 0.1 M dithio-
threitol for an additional 15 min at 37 °C. Ubiquitin-conju-
gated proteins were detected by immunoblotting using mouse 
monoclonal antibodies against ubiquitin (Covance). 
Results
Cadmium Rapidly Induces Pca1 Expression by Increasing Sta-
bility—A unique feature of Pca1 is a cytosolic cysteine-rich 
N-terminal extension of nearly 400 residues (Figure 1A). To 
investigate the mechanism underlying the post-transcrip-
tional regulation and the role of the N-terminal extension in 
turnover of Pca1, we have constructed expression plasmids 
of full-length Pca1 and Pca1 with truncation of the first 392 
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amino acids. A GFP or triple HA epitope was fused at the N 
terminus. All of the Pca1 constructs were functional in con-
ferring cadmium resistance (Figure 1B). Western blot analy-
sis of Pca1 showed that Pca1 is a short-lived protein (t½ < 5 
min) (Figure 1C). However, up-regulation of Pca1 is clearly 
visible 5 min after the addition of cadmium to culture me-
dium (Figure 1D), indicating a rapid cellular response to cad-
mium. Pca1 tagged with the GFP or c-Myc epitope at the N or 
C terminus, respectively, also showed similar regulation by 
cadmium (data not shown), suggesting that the effect of cad-
mium on Pca1 expression is independent of epitope or its lo-
cation. This expression control by cadmium can be explained 
by enhanced translation or stability of Pca1 protein. To de-
cipher these two possibilities, Pca1 turnover rate was exam-
ined by cycloheximide chases in the absence or presence of 
cadmium in culture media. Indeed, stability of Pca1 is dra-
matically increased in the presence of cadmium (Figure 1E). 
These data suggest that the induction of Pca1 occurs through 
the ability of cadmium to prevent the rapid turnover of Pca1. 
Pca1 Is Not Stabilized in a Strain Defective in Endocytosis—
In yeast, several plasma membrane proteins are internalized 
into endocytic vesicles that enter the early endosome where 
they can be recycled back to the surface or are delivered to 
the vacuole for degradation (40, 41). We considered that Pca1 
might be transiently localized at the cell surface before being 
rapidly internalized and degraded. In this pattern of traffick-
ing, cadmium sensing would shift the distribution of Pca1 to 
the cell surface for cadmium efflux. If the internalization step 
were to be blocked, then Pca1 would be expected to accumu-
late at the plasma membrane in the absence of cadmium. To 
test this possibility, we investigated the subcellular localiza-
tion of Pca1 fused with GFP (Figure 1B) in a strain harboring 
a temperature-sensitive allele of END4. This strain exhibits 
conditional defects in both fluid phase and receptor-medi-
ated endocytosis at the restrictive temperature (31). Confocal 
microscopy revealed that GFP-Pca1 expressed in the end4-1 
mutant at the restrictive temperature did not accumulate at 
the plasma membrane (data not shown) and remained un-
stable as demonstrated by cycloheximide chase (Figure 2A). 
The defect in endocytosis was confirmed by inhibition of in-
ternalization of the membrane impermeable dye, Lucifer Yel-
low CH (31) in the end4-1 strain at the restrictive temperature 
(data not shown). These results suggest that Pca1 turnover 
in the absence of cadmium occurs either at the plasma mem-
brane or before sorting to the plasma membrane. 
Pca1 Degradation Is Dependent on the Proteasome But Not Vac-
uolar Proteases—Plasma membrane proteins can be directly 
sorted to the vacuole for degradation. For instance the Gap1 
amino acid permease is directly targeted to the vacuole when 
preferred nitrogen sources are available (42). Perhaps in an 
analogous manner Pca1 may sense cadmium before traffick-
ing to the plasma membrane or is otherwise degraded by the 
vacuole. To test this, we examined localization and turnover 
rate of Pca1 in a Δpep4 strain that is deficient in vacuolar pro-
tease activity (43). GFP-Pca1 did not accumulate in the vacu-
ole of the Δpep4 strain, which was distinct from Fet3-GFP, a 
cell surface iron oxidase, previously shown to undergo vacuo-
lar degradation (44) (data not shown). A cycloheximide chase 
confirmed that Pca1 undergoes degradation at a similar rate in 
the Δpep4 background compared with an isogenic wild type 
strain (Figure 2B), suggesting no significant role for vacuo-
lar proteases in degradation of Pca1. The dependence of Pca1 
degradation through the vacuolar/endosomal pathway was 
further examined in a Δvps4 strain, which is defective in both 
anterograde (late endosome-to-vacuole) and retrograde (late 
endosome-to-Golgi) trafficking (74). Resident proteins of the 
late endosome are typically trapped in prevacuolar compart-
ments/multivesicular bodies in Δvps4 cells. As shown in Fig-
ure 2C, GFP-Pca1 does not accumulate in such compartments 
in the Δvps4 mutant, unlike Fet4-GFP, which undergoes vac-
uolar degradation. We conclude that Pca1 degradation is not 
dependent on the vacuolar degradation pathway. 
Given that Pca1 turnover is not dependent on vacuolar 
proteases, we questioned whether the rapid degradation of 
Pca1 was dependent upon the proteasome. Indeed, treatment 
of cells with the protease inhibitor MG132 led to a significant 
increase in Pca1 expression compared with vehicle-treated 
controls (Figure 2D). This experiment was performed in a 
Δpdr5 strain, previously shown to limit the efflux of protease 
Figure 1. Cadmium rapidly enhances Pca1 expression by increas-
ing stability. A, schematic depiction of the Pca1 P1B-type ATPase. Gray 
and black rectangles represent the N-terminal cysteine-rich cytosolic 
domain encompassing the first 392 amino acids and eight predicted 
transmembrane domains, respectively. B, cadmium resistance in cells 
expressing Pca1 alleles. Pca1, N-terminal GFP-fused Pca1 (GFP-Pca1), 
three tandem HA epitope-tagged Pca1 (HA-Pca1), and Pca1 deleted of 
the N-terminal cysteine-rich domain (Pca1Δ392) with or without N-
terminal GFP fusion were expressed in a BY4741 yeast strain in which 
endogenous Pca1 is nonfunctional (30). The cells (5 µl, A600 = 1.0) were 
spotted on SC solid medium containing the indicated concentration of 
CdCl2, and then cell growth was assessed after 2 days. C–E, HA-Pca1 
expression was detected by Western blotting using anti-HA antibod-
ies. The same blot was probed for PGK to determine equal loading. 
C, cycloheximide chase of yeast cells expressing HA-Pca1. Exponen-
tially growing cells were co-cultured with cycloheximide (100 µg/ml) 
and then collected at the indicated time points for Western blot analy-
sis. D, rapid up-regulation of Pca1 in response to cadmium. Cadmium 
(50 µM CdCl2) was added to exponentially growing yeast cultures, 
and then the cells were collected into ice-cold kill buffer (15 mM NaN3 
PBS) at the indicated time points. E, cadmium-induced stabilization of 
Pca1 determined by cycloheximide chase. Yeast cells precultured for 
15 min without (NT) or with cadmium (20 µM CdCl2) were collected 
at the indicated time points. Cycloheximide (100 µg/ml) was added to 
the culture medium after collection of time zero. Total protein extracts 
were subjected to Western blot analysis.
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inhibitors (34). We also examined the steady state expres-
sion of Pca1 in a pre1-1 pre2-1 double mutant, which is de-
fective in proteasomal activity (33). Consistently, Pca1 is sta-
bilized in this strain although to a much lesser extent, which 
is likely due to some remaining proteolytic activities in the 
pre1-1 pre2-1 strain that participates in Pca1 degradation (Fig-
ure 2E). Consistent with the fact that ubiquitination is a pre-
requisite for proteasomal targeting, ubiquitination of Pca1 
was readily detectible (Figure 2F). However, it is diminished 
to nondetectable levels after cells are exposed to cadmium 
(Figure 2F). This observation hints toward a mechanistic ex-
planation for the role of cadmium in preventing the degra-
dation of its own exporter. Rsp5 is an E3 ubiquitin-protein 
ligase that is known to be involved in regulation of several 
plasma membrane proteins, such as metal-dependent down-
regulation of the Znt1 zinc transporter and Smf1 manganese 
transporter (40). However, an Rsp5-deficient strain did not 
stabilize Pca1 (data not shown), suggesting no role for this 
ubiquitin-protein ligase in Pca1 turnover. 
To exclude the possibility that stabilization of Pca1 by 
cadmium may reflect toxic effects of cadmium on the cellu-
lar systems for ubiquitination and proteasomal degradation, 
we tested the effects of cadmium 
on the expression of GFP-CL1 
that has been utilized as a re-
porter for determining the activ-
ities of the ubiquitination-prote-
asome pathway (45). As shown 
in Figure 2G, cadmium exposure 
at the same concentrations that 
markedly stabilize Pca1 (Figure 
1E) had no significant influence 
on the expression levels of GFP-
CL1. Thus, cadmium inhibition of 
proteasomal degradation of Pca1 
is specific. Our previous data also 
showed that Pca1 protein expres-
sion is enhanced when yeast cells 
are exposed to cadmium as low as 
1 µM concentrations (30), which 
are similar to those found in plants 
where natural yeast cells grow (6). 
The Cysteine-rich Cytosolic Ex-
tension Contains a Degradation Sig-
nal—We postulated that the cys-
teinerich N-terminal extension 
of Pca1 might contain a metal-re-
sponding degradation signal. In-
deed, whereas full-length Pca1 
is hardly detectable in the ab-
sence of copper or cadmium, dele-
tion of this domain (Pca1Δ392) re-
sulted in constitutive expression 
at the cell surface even in the ab-
sence of cadmium (Figure 3, A 
and B). These data strongly sug-
gest that Pca1 turnover occurs via 
this domain. Consistent with the 
idea that Pca1 ubiquitination is 
dependent on a degradation sig-
nal within the N-terminal domain, 
ubiquitination was not detected 
in Pca1Δ392 (Figure 3C). Although the Pca1(1–392) domain 
is necessary for Pca1 turnover, co-expression of this domain 
with Pca1Δ392 separately did not lead to enhanced turnover 
of Pca1Δ392 (data not shown). This suggests that to serve as a 
degradation signal for Pca1, this domain should be associated 
with the entire protein. 
To determine whether the N-terminal regulatory domain 
is sufficient for controlling the expression of another plasma 
membrane transporter, we fused the peptide comprising 
amino acid residues 1–392 of Pca1 to the N terminus of a cop-
per-transporting P1B-type ATPase (CaCRP) identified from 
Candida albicans (46, 47) and then expressed in S. cerevisiae. 
The Pca1(1–392)-CaCRP fusion was fully functional in con-
ferring copper tolerance to yeast cells indicating correct fold-
ing and trafficking (Figure 4A). Confocal microscopy (Figure 
4B) and Western blot analysis (Figure 4C) demonstrated that 
residues 1–392 in Pca1 control CaCRP expression specifically 
in a cadmium- and copper-dependent manner. Hence, this 
domain functions as an autonomous degradation signal that 
can be masked when cells are growing in medium supple-
mented with cadmium or copper. 
We aligned this domain with characterized P1B-type 
Figure 2. Proteasome-dependent degradation of Pca1 and prevention of ubiquitination by cadmium. 
A, cycloheximide chase and Western blotting of HA-Pca1 expressed in end4-1 strain and isogenic paren-
tal strain (WT). The cells were cultured at 37 °C for 2 h to block endocytosis and collected at the indicated 
time points for Western blot analysis. B, cycloheximide chase of HA-Pca1 expressed in Δpep4 strain and 
isogenic parental (WT) strain. C, confocal microscopy of GFP-fused Pca1 or Fet4 expressed in Δvps4 or 
isogenic parental (Wt) strains. D, empty vector or HA-Pca1 was expressed in Δpdr5 cells in which prote-
asome inhibitor efflux is reduced (34). The cells were cultured in the presence (+) or absence (–) of pro-
teasome inhibitor MG132 (40µM, 5 h). Total protein extracts were subject to Western blot analysis using 
anti-HA antibodies. E, HA-Pca1 was expressed in a temperature-sensitive pre1-1 pre2-1 proteasome de-
fective mutant or isogenic parental strain (WT) at restrictive temperature (37 °C) for 2 h. Relative expres-
sion of HA-Pca1 was detected by anti-HA immunoblotting. F, cadmium inhibits Pca1 ubiquitination. 
Cells expressing HA-Pca1 were cultured with (+) or without (–) cadmium (50 µM CdCl2, 2 h). HA-Pca1 
in total protein extracts was immunoprecipitated with beads conjugated with anti-HA antibodies. HA-
Pca1 and ubiquitin-attached HA-Pca1 were detected by immunoblotting using anti-ubiquitin (Ub) and 
anti-HA antibodies. The arrow indicates the expected migration of nonubiquitinated HA-Pca1. G, cad-
mium does not stabilize a model substrate of the ubiquitination-proteasome degradation pathway. Ex-
pression levels of GFP-CL1 were detected in cells precultured for 1 h without (NT) or with cadmium (50 
µM CdCl2). Cycloheximide (100 µg/ml) was added to the culture medium after collection of time zero. 
Total protein extracts prepared from cells collected at the indicated time points were subjected to West-
ern blot analysis using anti-GFP antibodies. PGK was probed to determine equal loading.
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ATPases and other proteins. However, the Pca1 N-terminal 
domain does not possess any significant sequence similarity 
to known proteins. Therefore, we employed a mapping strat-
egy to define a signal sequence of metal-dependent degrada-
tion. Serial deletions of the N terminus and fusion of various 
Pca1 N-terminal fragments to CaCRP were made (Figure 5A) 
and then expressed in yeast cells. Characterization of expres-
sion levels and metal-dependent stabilization using confo-
cal microscopy revealed that a region encompassing residues 
250–350 (Pca1(250–350)) is necessary and sufficient for both 
rapid turnover and cadmium or copper-dependent stabili-
zation (Figure 5, A and B). Because the Pca1(250–350) degra-
dation signal likely interacts with cellular factor(s) necessary 
for Pca1 degradation, we hypothesized that excess expres-
sion of this domain would compete for degradation of full-
length Pca1. Indeed, co-expression of the Pca1(250–350) pep-
tide with Pca1 leads to enhanced expression of Pca1 (Figure 
5C). Collectively, these data indicate that this Pca1(250–350) 
contains a degradation signal that can be masked by metal 
sensing. 
Cysteine Residues within the Pca1 Regulatory Domain Are Re-
quired for Metal Sensing—This 250–350-amino acid peptide 
contains seven cysteine residues (Figure 6A). Given that cys-
teine is a known metal ligand, we predicted metal ion bind-
ing to this domain. A Pca1(250–350) peptide tagged with 
three tandem copies of HA epitope (HA-Pca1(250–350)) was 
expressed in Δace1 or Δycf1 strains that are sensitive to cop-
per or cadmium, respectively (24, 25). We hypothesized 
that this peptide would bind and sequester metal ions like 
metallothionein (20), which would confer resistance to cop-
per and cadmium. Growth assays on media containing cop-
per or cadmium at toxic levels showed that cells expressing 
HA-Pca1(250–350) displayed cadmium and copper resistance 
compared with empty vector transformed cells (Figure 6B). 
However, this peptide did not confer zinc tolerance in a zinc-
sensitive strain (data not shown). These data are in accor-
dance with previous observations in which copper and cad-
mium but not zinc stabilized Pca1 (Figure 3A) and CaCRP 
fused with this regulatory domain (data not shown). The 
same peptide in which all cysteine residues are substituted 
to alanine (ΔCys) did not confer metal resistance (Figure 6B), 
supporting roles for cysteine residues in metal binding. To 
ensure equal or greater levels relative to the wild type pep-
tide (Figure 6D), we expressed HA-Pca1(250–350) ΔCys pep-
tide using a high copy plasmid. 
We next examined which cysteine residues within this do-
main play roles for conferring resistance to cadmium and/
or copper. Site-directed mutation of the CXC motif (C298A, 
C300A) abolished copper resistance but not cadmium re-
sistance (Figure 6C). Conversely, mutation of the CC motif 
(C311A,C312A) abolished cadmium resistance yet retained 
the ability to confer copper resistance (Figure 6C). These data 
support distinct roles for these cysteine residues in copper or 
cadmium coordination. 
We predicted that cysteine mutations would compromise 
metal-dependent masking of the degradation signal. Indeed, 
cadmium or copper could not stabilize CaCRP fused with 
HA epitope-tagged Pca1(250–350) where all seven cysteine 
residues were substituted to alanine (ΔCys) (Figure 6E, upper 
panel, fifth and sixth lanes). However, steady state expression 
levels without metal addition to culture media (NT) were 
not significantly different between control (WT) and cysteine 
Figure 3. The cysteine-rich N terminus of Pca1 contains a degradation 
signal. A, metal-dependent expression of GFP-Pca1 or GFP-Pca1Δ392. 
Cells expressing GFP-Pca1 or GFP-Pca1Δ392 were cultured in the ab-
sence (NT) or presence of metal ions (50µM CuCl2 (Cu), 50µM CdCl2 
(Cd), or 15 mM ZnCl2 (Zn) for 1 h). GFP fluorescence in cells was visu-
alized by confocal microscopy. A copper-sensitive Δace1 strain (24) was 
used for these experiments presented in both A and B. B, Western blot-
ting of GFP-Pca1 and GFP-Pca1Δ392 in cells cultured with (+) or with-
out (–) cadmium (50µM CdCl2 for 2 h) using anti-GFP antibodies. The 
asterisks indicate nonspecific bands. The top arrow indicates full-length 
GFP-Pca1, and the bottom arrow indicates GFP-Pca1Δ392. C, ubiquitina-
tion of Pca1 is dependent on the N-terminal domain. HA-Pca1 and HA-
Pca1Δ392 were immunoprecipitated and then detected by Western blot-
ting using anti-ubiquitin (Ub) and anti-HA antibodies.
Figure 4. The N-terminal cytosolic extension of Pca1 is an auto-regu-
latory domain that can be masked by cadmium and copper. A, yeast 
cells expressing GFP-tagged wild type CaCRP or CaCRP fused with the 
first 392 amino acids of the N terminus of Pca1 (Pca1(1–392)) were spot-
ted on solid medium containing toxic copper (CuCl2, 0.1 mM). B, ex-
pression of GFP-CaCRP and GFP-Pca1(1–392)-CaCRP in cells cultured 
with CuCl2 or CdCl2 (50µM, 2 h) were determined by visualization of 
GFP fluorescence with confocal microscopy. C, Western blot analysis of 
cells cultured as described above (B) using anti-GFP antibodies. A cop-
per-sensitive Δace1 strain (24) was used for these experiments.
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mutant (ΔCys) (Figure 6E, upper panel, first lane versus fourth 
lane), suggesting that cysteine residues are specifically nec-
essary for cadmium- or copper-induced stabilization but not 
turnover. Collectively, these data suggest that cysteine-based 
metal sensing within a cis-acting degradation signal serves as 
a molecular switch for rapid up-regulation of Pca1. 
Discussion 
Our data reveal a new mode of expressional control of a 
metal-transporting P1B-type ATPase. In the absence of cad-
mium, Pca1 is rapidly targeted for degradation at the prote-
asome via an N-terminal degradation signal. However, cad-
mium sensing allows Pca1 to circumvent degradation, which 
is likely attributed to conformational changes within the deg-
radation signal induced by metal binding. Hence, the cells 
are able to rapidly express Pca1 at the cell surface only when 
Pca1 is required for cadmium efflux. 
Because cadmium is extremely toxic and cadmium levels 
in the environment fluctuate, transcriptional or translational 
regulation of a cadmium detoxification system may not be 
fast enough for cell protection. The constant synthesis of Pca1 
would be an obvious advantage in coping with this problem. 
The underlying reason for rapid degradation of Pca1 could 
be explained by the fact that Pca1 ex-
pression is not necessary when cells 
are growing without cadmium stress. 
However, other factors may be im-
portant for keeping Pca1 levels at a 
minimum. For example, Pca1 could 
play another role other than cad-
mium efflux (e.g. efflux of nutritional 
metals), which would be deleterious 
in the absence of cadmium. Indeed, it 
was shown that cells overexpressing 
Pca1 grow slowly (48). If Pca1 trans-
ports nutritional metal ions because 
of broad substrate specificity, as 
shown for several other metal-trans-
porting P-type ATPases (26–28), ex-
pression of Pca1 only when cadmium 
is in excess could prevent loss of es-
sential metals that are limiting for 
growth. Although our previous data 
showed that Pca1 does not change 
cellular accumulation of zinc, man-
ganese, cobalt, or iron (30), Pca1 may 
transport these or other metal ions 
under specific growth conditions. 
Second, it is not known what form(s) 
of cadmium and other metals are sub-
strates of P1B-type ATPases. Ycf1, a 
vacuolar cadmium ATP-binding cas-
sette transporter in yeast, transports 
both glutathione-conjugated cad-
mium and glutathione itself (25, 49). 
A recent report showed that cysteine 
dramatically increases the activities 
of CopA, ZntA, and HMA2 P1B-type 
ATPases (50). Pca1 may extrude cys-
teine, glutathione, or other ions such 
as sulfur with or without conjugation 
of cadmium. If so, constitutive extrusion of these cellular fac-
tors would be deleterious, because they are critical for redox 
homeostasis and metabolism (51, 52). Alternatively, cysteine 
or other cytosolic molecules may activate Pca1 as shown for 
ZntA and HMA2 (50), resulting in constitutive ATP hydroly-
sis in the absence of cadmium. 
Internalization followed by degradation at the vacuole is 
a major pathway for turnover of plasma membrane proteins. 
For example, Zrt1 zinc transporter, Fet3/Ftr1 iron transporter 
complex, and Smf1 manganese transporter are subject to this 
mode of post-translational regulation (40, 44, 53, 54). Given 
that these transporters play roles in metal ion uptake, they 
are down-regulated when cells are exposed to excess metal 
ions. Substrate-dependent mono or poly-ubiquitination of 
membrane transporters is often a signal that triggers turn-
over of these transporters by endocytosis followed by vac-
uolar degradation (40). However, Pca1 regulation is distinct 
when compared with other metal ion transporters in that it is 
rapidly up-regulated by substrate-dependent rescuing from 
degradation. Anti-ubiquitin immunoblotting suggests that 
Pca1 is poly-ubiquitinated to multiple species in the absence 
of cadmium. Because a stable Pca1 deleted of the first 392 
amino acids is not ubiquitinated, this modification is likely 
Figure 5. The N-terminal domain encompassing amino acids 250-350 is necessary and sufficient for 
the control of Pca1 and CaCRP expression in a metal-dependent manner. A, Pca1 with or without 
N-terminal truncations and Pca1 N-terminal fragments fused with CaCRP were expressed in yeast. A 
GFP was tagged in frame at the N terminus of these expression constructs for visualization. Steady 
state GFP fluorescence in cells growing exponentially was scored as weak (–) or strong (+) by confo-
cal microscopy. Cadmium (50 µM CdCl2 for 2 h)-dependent enhancement (+) of GFP fluorescence 
was determined. B, confocal microscopy of GFP-Pca1(250–350)-CaCRP fusion in cells cultured in the 
absence (NT) or presence of metals (50 µM CuCl2 (Cu) or CdCl2 (Cd) for 2 h). C, determination of HA-
Pca1 expression levels in cells with (+) or without (–) co-expression of the Pca1(250–350) peptide. HA-
Pca1 was detected by immunoblotting with anti-HA antibodies. PGK in the same blot was probed as 
a loading control. A copper-sensitive Δace1 strain (24) was used for these experiments (A and B).
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Figure 6. Cysteine residues within the regulatory domain of Pca1 are required for metal sensing. A, 
sequence of a metal-responsive degradation signal encompassing amino acids 250–350 in the N termi-
nus of Pca1. Seven cysteine residues are in bold type. Cys298, Cys300, Cys311, and Cys312 are underlined. 
B, empty vector (V), a single-copy expression vector of N-terminal triple HA-tagged Pca1(250–350) 
(HA-Pca1(250–350), WT), and a multi-copy expression vector of HA-Pca1(250–350) with substitution 
of all seven cysteine residues to alanine (ΔCys) were transformed into copper-sensitive Δace1 (24) and 
cadmium-sensitive Δycf1 (25) strains. Cells growing exponentially were spotted on SC medium with-
out (NT) or with supplementation of toxic copper or cadmium (50 µM CuCl2 (Cu) or CdCl2 (Cd)). Cell 
growth was assayed after 2 days. C, empty vector (V) and an expression vector of HA-Pca1(250–350) 
possessing specific cysteine mutations as indicated were transformed into cells. Cell growth was de-
termined as described above (B). D, Western blotting of the HA-Pca1(250–350) peptides in total pro-
tein extracts of cells described above (B) with anti-HA antibodies. PGK was detected to determine 
equal loading. E, CaCRP fused with HA-Pca1(250–350) at the N terminus without (WT) or with site-
directed mutagenesis of all seven cysteine residues to alanine (ΔCys) were expressed in a Δace1 strain. 
Total protein extracts of cells cultured without (NT) or with copper or cadmium (20 µM CuCl2 or 
CdCl2 for 1 h) were subject to Western blot analysis using anti-HA and anti-PGK antibodies.
the signal for degradation. However, given the fact that Pca1 
functions at the plasma membrane to extrude cadmium, pro-
teasome-dependent turnover of Pca1 is a unique example. 
To the best of our knowledge, HMG-CoA reductase, which 
resides within the endoplasmic reticulum membrane is the 
only known polytopic membrane protein that is degraded 
by the proteasome in a regulated manner (75). Cellular ste-
rol metabolic status regulates the turnover of this rate-limit-
ing enzyme of ergosterol synthesis (75). In addition, several 
mutated polytopic membrane proteins are removed from the 
endoplasmic reticulum via the endoplasmic reticulum-as-
sociated degradation system in which the proteasome is in-
volved (76). This mechanism of turnover is known as a pro-
tein quality control pathway that plays an important role for 
the elimination of terminally misfolded proteins. However, 
Pca1 is a naturally expressed and functional protein that is 
regulated according to cellular needs. It is interesting to note 
that cellular trafficking of Arn1, a transporter of an iron-sid-
erophore complex, is regulated by its substrate. Intracellular 
sensing triggers plasma membrane sorting of Arn1, and its 
cycling between the plasma membrane and endosomes is in-
duced by substrate binding at the cell surface (55, 56). A sim-
ilar mechanism may control the sorting of Pca1 to the plasma 
membrane after substrate sensing. We are currently pursu-
ing the identification of trans-acting molecular factors in-
volved in this process. 
Most P1B-type ATPases possess N-terminal metal-bind-
ing domains (MBDs) that are thought to play roles in catal-
ysis and/or regulation. The conserved MBD (~70 amino ac-
ids, ββββ fold) contains a GMXCXXC sequence in which 
distribution (60). An inhibitory role of the N terminus of a 
copper transporting ATPase has been proposed as well (61). 
Interestingly, a recent report (62) suggested the presence of 
either additional regulatory copper-binding site(s) within the 
protein or another unknown mechanism for copper sensing. 
Collectively, whereas significant progress in the characteriza-
tion of conserved MBDs in N terminus of P1B-type ATPases 
has been made, the functional roles of these domains remain 
elusive. 
We have identified a distinct MBD in the N terminus of 
Pca1 that is necessary for extremely efficient control of Pca1 
expression in response to cadmium. Several atypical MBDs 
have been identified in other P1B-type ATPases as well. The 
core sequence of N-terminal MBDs of Arabidopsis thaliana 
HMA2–4 is substituted by a degenerate sequence, GICC(T/
S)SE (63). HMA2 and HMA4 zinc ATPases possess C-ter-
minal MBDs (several di-cysteine pairs and an 11-histidine 
stretch) that regulate enzyme activities (63, 64). A CHHC 
predicted metal-binding sequence was identified at the C ter-
minus of the CopA copper ATPase in Archaeoglobus fulgidus 
(65). The histidine-rich N-terminal metal-binding domain 
of the CopB copper ATPase in A. fulgidus appears to have a 
regulatory role affecting metal transport rates by controlling 
metal release (66). In addition to heavy metal-transporting 
P1B-type ATPases, it was also shown that Ca2+-transporting 
P-type ATPases carry inhibitory domains (67). Cytosolic reg-
ulators and phosphorylation of C-terminal residues control 
activities of H+-transporting ATPases in plants (68). Hence, 
auto-regulatory mechanisms may be widespread in P-type 
ATPases. 
two cysteine residues coordinate 
a metal ion (3, 29). Although this 
domain is conserved in many P1B-
type ATPases, the numbers of it 
vary, ranging from one to six. The 
N terminus of Pca1 contains only 
one conserved MBD in which 
two cysteine residues are essen-
tial for function (30). Human cop-
per transporting ATPases pos-
sess six MBDs at the N terminus. 
The Atx1 metallochaperone deliv-
ers copper through direct docking 
to MBDs with different prefer-
ences among them (57–59), sug-
gesting distinct functions of these 
domains. The structure and metal 
coordination of MBDs are rela-
tively well characterized; how-
ever, the roles for these domains 
in ATPase function are not yet 
clear. Copper binding was ini-
tially proposed as a substrate rec-
ognition step followed by trans-
fer of metal to the translocation 
pore. However, site-directed mu-
tagenesis and deletion of MBDs 
suggest a regulatory role. For ex-
ample, the fifth or sixth MBD of 
human ATP7a is necessary and 
sufficient for copper-induced re-
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We propose that direct metal binding to the Pca1(250–350) 
domain induces conformational changes that would mask a 
signal recognized by the protein degradation machinery. Ex-
pression of Pca1(250–350) itself confers both cadmium and 
copper tolerance, which supports the conclusion that this do-
main directly binds metals. Substitution of cysteine residues 
within this domain abolished metal resistance, suggesting a 
role for cysteines in metal coordination. Site-directed muta-
tion of cysteine residues suggests that binding site(s) of cad-
mium and copper do not overlap directly. Given that Pca1 
does not transport copper (30), the physiological significance 
of the stabilization of Pca1 by copper is not obvious at this 
moment. It is necessary to point out that in a copper-sensi-
tive Δace1 strain, Pca1 stabilization by copper is observed at 
similar concentrations to that of cadmium; however, in wild 
type cells a relatively high copper concentration (~2 mM) is 
required for Pca1 stabilization (data not shown). CUP1- and 
CRS5-encoded metal chelators that are up-regulated by Ace1 
likely have higher affinity to copper than the N terminus of 
Pca1. 
Fusion of the Pca1(250–350) domain with a stable pro-
tein leads to rapid turnover and metal-dependent stabiliza-
tion, demonstrating a role as an autonomous and metal-re-
sponsive degradation signal. However, this domain does not 
carry significant sequence identity with characterized degra-
dation signals or known proteins. Given that Pca1(250–350) 
is located in the middle of the N terminus, the N-end rule 
pathway of protein degradation is not likely involved in Pca1 
degradation (69). Pro, Glu, Ser, and Thr amino acid-enriched 
sequence (PEST sequence) is a proteolytic signal (70). How-
ever, Pca1 250–350 is not predicted to contain a PEST signal. 
It has been proposed that exposure of hydrophobic residues 
could recruit molecular chaperones, which results in re-
folding to a functional protein or targeting for degradation. 
Structural characterization of this domain in apo and cad-
mium-bound forms would reveal what characteristics lead to 
degradation of Pca1 and how metal binding masks this deg-
radation signal. We are currently pursuing characterizations 
of structure and metal binding of this domain in detail; how-
ever, purification of ample quantities of the Pca1(250–350) 
peptide has been a technical challenge (D. J. Adle and J. Lee, 
unpublished data). 
It is interesting to note that the N terminus of a human 
copper ATPase interacts with several proteins, although the 
physiological significance of these interactions remains to be 
elucidated. For example, MURR1/COMMD1 binds with the 
N terminus of ATP7b, which decreases the stability of newly 
synthesized ATP7b (71). A hepatocytic isoform of the PLZF 
(promyelocytic leukemia zinc finger) protein interacts with 
the C terminus of ATP7b, which positively regulates extra-
cellular signal-regulated kinase (ERK) signal transduction 
(72). Glutaredoxin interacts with the N terminus of ATP7a 
and ATP7b (76), and the dynactin subunit p62 interacts with 
the N terminus of ATP7b (73). These protein-protein inter-
actions may play critical roles for the function, regulation of 
catalytic activities, and/or subcellular trafficking of ATP7b 
and possibly other P1B-type ATPases. The regulatory domain 
identified at the N terminus of Pca1 may interact with acces-
sory protein(s) that target Pca1 to the ubiquitination-protea-
some pathway. 
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